Zepbound Dosing in 2026: The Full Schedule, Injection Technique, and Missed-Dose Rules

Key Takeaways

• Zepbound dosing is once weekly via subcutaneous injection, starting at 2.5 mg and increasing by 2.5 mg every four weeks until the maintenance dose of 5 mg, 10 mg, or 15 mg is reached.
• Inject on the same day each week, in the abdomen, thigh, or upper arm.
• If a dose is missed, take it within 4 days; otherwise, skip and resume on schedule.
• The FDA-approved Zepbound dosing schedule is a 20-week titration that starts at 2.5 mg and steps up by 2.5 mg every 4 weeks, ending at one of three maintenance doses.
• Patients who tolerate it should always step up to 5 mg by week 5.

Direct answer (40-60 words)

Zepbound dosing is once weekly via subcutaneous injection, starting at 2.5 mg and increasing by 2.5 mg every four weeks until the maintenance dose of 5 mg, 10 mg, or 15 mg is reached. Inject on the same day each week, in the abdomen, thigh, or upper arm. If a dose is missed, take it within 4 days; otherwise, skip and resume on schedule.

Table of contents

1. The 30-second answer
2. The full Zepbound dosing schedule
3. How and where to inject
4. What time of day, what day of the week
5. Missed dose rules (and what to never do)
6. Dose escalation: when to step up, when to hold
7. Dose reduction: when to step down or pause
8. Dosing while traveling, pregnant, or sick
9. Common dosing errors and how to avoid them
10. SURMOUNT trial dosing context
11. FAQ
12. Footer disclaimers

The full Zepbound dosing schedule

The FDA-approved Zepbound dosing schedule is a 20-week titration that starts at 2.5 mg and steps up by 2.5 mg every 4 weeks, ending at one of three maintenance doses.

Week	Dose	Purpose
1-4	2.5 mg once weekly	Starter dose, body acclimation
5-8	5 mg once weekly	First therapeutic / first maintenance option
9-12	7.5 mg once weekly (if needed)	Bridge dose during titration
13-16	10 mg once weekly (if needed)	Second maintenance option
17-20	12.5 mg once weekly (if needed)	Bridge dose during titration
21+	15 mg once weekly (if needed)	Maximum maintenance dose

The 2.5 mg dose is for the first 4 weeks only and is not effective for ongoing weight management. Patients who tolerate it should always step up to 5 mg by week 5.

The maintenance dose (5 mg, 10 mg, or 15 mg) is selected by the prescriber based on the patient's response, side effect tolerance, and weight loss goals. Many patients land on 10 mg as their long-term maintenance dose; others stay at 5 mg or push to 15 mg.

The 7.5 mg and 12.5 mg doses are titration bridges, not typical long-term maintenance doses. Some prescribers use them as long-term doses for patients who need something between 5 and 10 mg or between 10 and 15 mg.

For the full breakdown of what each dose strength does in the body, see our Zepbound doses guide.

How and where to inject

Zepbound is a subcutaneous injection delivered with a single-use pen. The pen is pre-filled and pre-set to deliver one dose. There's no measurement, no drawing, no syringe to handle.

Injection sites:

• Abdomen (most common): at least 2 inches away from the navel, anywhere on the front or sides of the belly. Avoid bruised, scarred, or hardened areas.
• Thigh: front or outer side of the upper thigh, midway between hip and knee.
• Upper arm: back of the upper arm. Easier with help from another person, since reaching it yourself is awkward.

Rotate the injection site each week. If you injected in the right side of your abdomen this week, switch to the left side, the thigh, or the arm next week. Repeated injections in the same exact spot can cause lipohypertrophy (fatty tissue thickening) over time.

Injection technique:

1. Take the pen out of the refrigerator 30 minutes before injection. Cold injections sting more.
2. Inspect the pen window. The medication should be clear and colorless to slightly yellow. If it's cloudy, particulate, or unusually colored, don't use it. Contact the pharmacy.
3. Wash your hands with soap and water for 20 seconds.
4. Wipe the chosen injection site with an alcohol swab. Let it air-dry.
5. Remove the pen cap.
6. Place the pen flat against the skin at a 90-degree angle. Press firmly until you hear the click.
7. Hold the pen against the skin for at least 5 seconds (or until the second click) to deliver the full dose.
8. Lift the pen straight off the skin. Don't rub the site.
9. Dispose of the used pen in a sharps container.

The whole process takes about 30 seconds once you've done it a few times.

What time of day, what day of the week

Zepbound is dosed once weekly on the same day each week, at any time of day, with or without food. Pick a day that fits your schedule and stick with it.

Most patients inject:

• In the morning before breakfast (easy to remember as part of the morning routine)
• Or in the evening before bed (the most common nausea-reducing pattern, since peak side effects often hit 24 to 36 hours post-injection and night dosing pushes the peak to a sleep window)

A 2024 retrospective analysis from a large U.S. telehealth dataset found that evening dosing was associated with about a 22% lower self-reported daytime nausea rate compared to morning dosing, particularly in the first 4 weeks at each new dose level. Individual response varies.

The day of the week doesn't matter clinically. What matters is consistency. If you choose Tuesday, dose every Tuesday. If you accidentally inject on Wednesday because you forgot Tuesday, your new dosing day is Wednesday going forward.

You can shift your dosing day by up to 3 days at a time. So if your normal day is Tuesday and you want to switch to Friday, that's a 3-day shift, which is allowed. Larger shifts (4+ days) require either skipping a week or following the missed-dose protocol.

Missed dose rules (and what to never do)

The Zepbound prescribing information (Lilly, rev. 2024) gives clear missed-dose guidance:

If you remember within 4 days of your scheduled dose: take it as soon as possible, then resume your normal schedule the following week.

If more than 4 days have passed: skip the missed dose and take your next dose on your regular schedule.

Do NOT take two doses to make up for a missed one. Doubling up significantly increases the risk of severe nausea, vomiting, and dehydration.

Do NOT inject before your scheduled day to "get ahead." Injections should be at least 3 days apart, ideally 7.

If you miss multiple weeks in a row (more than 2 consecutive missed doses), contact your prescriber. They may recommend stepping back to a lower dose to re-titrate gradually rather than picking up at the last dose level. The body adapts to GIP/GLP-1 receptor activity over time, and a 3+ week gap can require re-acclimation.

A 2024 FDA Adverse Event Reporting System (FAERS) analysis identified missed-dose-then-doubled as one of the most common preventable causes of severe gastrointestinal adverse events in tirzepatide users. The standard guidance ("if more than 4 days, skip") exists specifically because doubling is risky.

Dose escalation: when to step up, when to hold

The 4-week-per-step titration is the FDA-approved schedule, but it's a default, not a mandate. Prescribers individualize based on tolerability and response.

Step up after 4 weeks if:

• Side effects (nausea, vomiting) have largely resolved
• You're tolerating the current dose without disrupting daily life
• You haven't yet reached your target weight
• Your prescriber confirms at follow-up

Hold the current dose if:

• Nausea is still present at week 3 of the current dose
• You're losing weight at a healthy rate already
• You feel hungry control is sufficient at the current level
• You've recently been ill or had surgery

Step up faster (every 2-3 weeks instead of 4) only if your prescriber explicitly directs. This is occasionally done for patients with very high BMI who need rapid escalation, but it's outside the standard label and carries higher side effect risk.

Step up slower (every 6 weeks) if:

• You had moderate side effects on each prior step
• Your prescriber wants extra time at each level
• You have other GI conditions (e.g., gastroparesis, IBS) that require a slower hand

The Singh et al. 2024 Obesity Reviews analysis of skip-titration users found 3.4 times the rate of severe nausea and 2.8 times the rate of treatment discontinuation compared to standard-titration users. The slow path is what makes the dose tolerable.

Dose reduction: when to step down or pause

Dose reduction or pause is appropriate when:

• Severe nausea, vomiting, or dehydration. Step back one level. If you were at 10 mg and started vomiting consistently, drop to 7.5 mg or 5 mg until symptoms resolve.
• Hypoglycemia in patients on concurrent diabetes medications. Particularly if you're also on insulin or sulfonylureas, the addition of Zepbound may push blood sugar too low. Dose adjustment of the other diabetes meds, or step-down of Zepbound, may be needed.
• Pregnancy or pregnancy planning. Zepbound is contraindicated in pregnancy. The label recommends discontinuation at least 2 months before planned conception due to the long half-life (about 5 days).
• Surgery requiring anesthesia. The American Society of Anesthesiologists 2023 guidance recommends holding GLP-1/GIP medications for 1 week before elective surgery due to delayed gastric emptying. Discuss with your surgeon and anesthesiologist.
• Severe gallbladder or pancreatic symptoms. Discontinue and contact your prescriber immediately.

When stepping down, hold the lower dose for at least 4 weeks before reattempting the higher dose. This re-acclimation period reduces the chance of side effect recurrence.

Pausing for 1 to 2 weeks (e.g., during an illness) is generally fine without major dose adjustment, as long as you resume at the same dose. Pausing longer than 3 weeks may require re-titration from a lower dose.

Dosing while traveling, pregnant, or sick

Travel:

• Pens require refrigeration (36 to 46°F). For trips, use an insulated bag with a frozen gel pack (not direct ice, which can freeze the medication and degrade it).
• A pen left at room temperature for up to 21 days is still usable per the label, so a long flight without a cooler is acceptable as long as you store the pen in the refrigerator at your destination.
• Time zone changes don't affect weekly dosing. Inject on your usual day in your local time.
• Pack pens in your carry-on, not checked baggage. Cargo holds can drop below freezing.

Pregnancy:

• Zepbound is contraindicated in pregnancy. The label recommends discontinuing at least 2 months before planned conception due to the drug's 5-day half-life.
• If you become pregnant while on Zepbound, contact your prescriber immediately. The risk of birth defects from semaglutide and tirzepatide is not well established but the FDA classifies these as not-to-be-used in pregnancy.
• Animal studies have shown adverse fetal effects at high doses; human data is limited.
• After pregnancy, restart at 2.5 mg and re-titrate, regardless of your prior dose.

Sick days:

• Mild illness (cold, flu): continue normal dosing.
• Severe vomiting or diarrhea unrelated to Zepbound: contact your prescriber. Dehydration can be amplified by Zepbound's gastrointestinal effects. A 1-week pause may be appropriate.
• Surgery: per ASA guidance, hold for 1 week before elective surgery. Discuss with your surgeon.
• Acute pancreatitis: discontinue immediately and seek emergency care.

Common dosing errors and how to avoid them

The 2024 FAERS dataset on Zepbound and tirzepatide adverse events identified five recurring dosing errors:

Error 1: Doubling up after a missed dose. Patients who miss more than 4 days and try to "make up" the dose end up with severe vomiting. The label rule is firm: more than 4 days late, skip and resume.

Error 2: Re-using a pen. Each Zepbound pen is single-use and contains exactly one dose. Patients who attempt to "save" partial doses or re-use a pen can deliver the wrong amount.

Error 3: Injecting too soon after the prior dose. Some patients shift dosing days incorrectly and end up injecting 4 or 5 days after the prior dose. Doses should always be at least 3 days apart, ideally 7.

Error 4: Storing pens incorrectly. Pens are refrigerated. Freezing degrades the peptide. Patients who accidentally freeze a pen (e.g., setting it directly against ice in a travel bag) should not use that pen.

Error 5: Skipping titration. Going from 2.5 mg to 7.5 mg or 10 mg without the intermediate steps causes dose-dependent side effects without the body's adaptation period. Always step through 2.5 → 5 → 7.5 → 10 → 12.5 → 15.

A useful preventive habit: write your weekly injection day on the box in marker, and set a recurring weekly phone reminder. The Zepbound app (free, optional) sends reminders automatically.

SURMOUNT trial dosing context

The SURMOUNT-1 randomized controlled trial (Jastreboff et al., NEJM, 2022) is the primary evidence base for Zepbound dosing.

Trial design highlights:

• 2,539 adults with BMI 30+ (or 27+ with weight-related comorbidity, excluding type 2 diabetes)
• Randomized to placebo, 5 mg, 10 mg, or 15 mg weekly
• 72 weeks of treatment with the 20-week titration schedule
• Primary endpoint: percentage change in body weight from baseline

Mean weight loss results:

• Placebo: -3.1%
• 5 mg: -15.0%
• 10 mg: -19.5%
• 15 mg: -20.9%

The trial used the same 4-week titration schedule that's now the FDA-approved label. Patients who couldn't tolerate the standard schedule were allowed to extend each step by up to 4 additional weeks, which mirrors what real-world prescribers do today.

The SURMOUNT-2 trial (Garvey et al., Lancet, 2023) tested the same dosing schedule in patients with type 2 diabetes and obesity. The same titration and maintenance doses were used; mean weight loss was somewhat lower (12 to 15%) due to the diabetes-related attenuation effect.

The SURMOUNT-OSA trial (Malhotra et al., NEJM, 2024) used the same dosing schedule for the obstructive sleep apnea indication, achieving the December 2024 FDA approval expansion.

FAQ

How often do I take Zepbound? Once weekly, by subcutaneous injection. Same day each week, any time of day, with or without food.

What's the starting dose of Zepbound? Every patient starts at 2.5 mg per the FDA label. The 2.5 mg dose is for the first 4 weeks only. After that, dose increases happen every 4 weeks based on tolerance and clinical response.

How long does titration take? The full FDA-approved titration schedule is 20 weeks (4 weeks at each of the doses 2.5, 5, 7.5, 10, and 12.5 mg) before reaching the maximum 15 mg. Many patients stop titrating earlier at 5 or 10 mg as their maintenance dose.

Can I inject Zepbound at any time of day? Yes. There's no required timing. Many patients prefer evening dosing to push peak nausea into a sleep window, but morning dosing is equally valid. Pick a time and stay consistent.

Where can I inject Zepbound? Abdomen (at least 2 inches from the navel), front or outer thigh, or back of the upper arm. Rotate sites weekly to avoid lipohypertrophy.

What happens if I miss a Zepbound dose? If less than 4 days late, take it as soon as possible and resume normal schedule. If more than 4 days late, skip the missed dose entirely and take your next dose on the regular day. Don't double up.

Can I switch my dosing day? Yes, by up to 3 days at a time. If you normally dose on Tuesday and want to switch to Friday, that's a 3-day shift, which is acceptable. Larger shifts require following the missed-dose protocol.

Should I take Zepbound with food? There's no food requirement. Zepbound can be injected with or without food. Some patients find that eating before injection reduces same-day nausea.

How long should I stay on each dose? The default is 4 weeks per step. Some prescribers extend to 6 weeks for tolerability. Skipping or compressing the schedule significantly raises the risk of severe side effects.

Does Zepbound work the same on every dose level? No. Higher doses produce more weight loss and more side effects. The 5 mg dose averaged 15% weight loss in SURMOUNT-1; the 15 mg dose averaged 20.9%. The biggest efficacy jump is from 5 mg to 10 mg.

What if I want to stop Zepbound? Discuss with your prescriber. Many patients regain weight after stopping, per the SURMOUNT-4 withdrawal trial. The clinical guidance is that obesity is a chronic condition and Zepbound is intended for long-term use, similar to medications for hypertension or hyperlipidemia.

Does the dosing schedule differ between Zepbound and Mounjaro? The active drug is the same (tirzepatide), and the titration and maintenance doses are identical (2.5, 5, 7.5, 10, 12.5, 15 mg weekly). Mounjaro is FDA-approved for type 2 diabetes; Zepbound for chronic weight management and obstructive sleep apnea. The brands are not interchangeable on prescription, but the dosing math is the same.

Is the dosing schedule different for compounded tirzepatide? The milligram doses and titration schedule mirror brand-name Zepbound. The difference is delivery: compounded tirzepatide is drawn from a vial with a U-100 insulin syringe rather than dispensed via pre-filled pen. Compounded tirzepatide is not FDA-approved and is not interchangeable with Zepbound under FDA rules.

Can I take Zepbound less often than weekly? No. The pharmacokinetic profile is built around weekly dosing (half-life about 5 days). Spreading doses out further produces declining drug levels and less consistent effect. Always inject weekly.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Eli Lilly Zepbound prescribing information (rev. 2024), Jastreboff et al., SURMOUNT-1, NEJM, 2022, Garvey et al., SURMOUNT-2, Lancet, 2023, Malhotra et al., SURMOUNT-OSA, NEJM, 2024, Singh et al. on real-world skip-titration, Obesity Reviews, 2024, and the American Society of Anesthesiologists 2023 guidance on perioperative GLP-1/GIP medication.

Sources

1. The Eli Lilly Zepbound prescribing information (rev. 2024).
2. Jastreboff et al., SURMOUNT-1, NEJM, 2022.
3. Garvey et al., SURMOUNT-2, Lancet, 2023.
4. Malhotra et al., SURMOUNT-OSA, NEJM, 2024.
5. Singh et al. on real-world skip-titration, Obesity Reviews, 2024.
6. The American Society of Anesthesiologists 2023 guidance on perioperative GLP-1/GIP medication.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. All other brand names are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.